Recruiting Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program NCT06265285 Conditions Adenocarcinoma, Advanced Esophageal Squamous Cell Carcinoma, Advanced Renal Cell Carcinoma, +81 more Locations Mayo Clinic in Florida — Jacksonville, Florida, United States View Trial Details
Completed Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer NCT01178944 Conditions Adenocarcinoma Of Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Carcinoma, +32 more Locations Roswell Park Cancer Institute — Buffalo, New York, United States Rochester General Hospital — Rochester, New York, United States View Trial Details
Completed Study of Docetaxel and Gemcitabine in Metastatic Esophageal Squamous Cell Cancer NCT01469598 Conditions Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +14 more Locations Samsung medical Center — Seoul, South Korea View Trial Details
Active, Not Recruiting Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer NCT01142388 Conditions Adenocarcinoma Of Esophagus, Carcinoma, Carcinoma, Squamous Cell, +21 more Locations Mayo Clinic in Arizona — Scottsdale, Arizona, United States Stanford Cancer Institute Palo Alto — Palo Alto, California, United States The Medical Center of Aurora — Aurora, Colorado, United States Boulder Community Foothills Hospital — Boulder, Colorado, United States View all 232 locations View more locations Show fewer locations Loading locations... View Trial Details
